250 MG Pill - blue oval, 12mm
Pill with imprint 250 MG is Blue, Oval and has been identified as Levetiracetam 250 mg. It is supplied by Secan Pharmaceuticals, Inc.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 250 MG
Levetiracetam
- Imprint
- 250 MG
- Strength
- 250 mg
- Color
- Blue
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Secan Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 43489-0121
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
polyethylene glycol 3350,
polyethylene glycol 6000,
polyvinyl alcohol,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 2,
indigotindisulfonate sodium,
aluminum oxide
Note: Inactive ingredients may vary.
Related images for "250 MG"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (429)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam (Intravenous) (Advanced Reading)
- Levetiracetam (Oral) (Advanced Reading)
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
